Cambridge Cognition Holdings (FRA:1M7) GF Score: 52/100 (As of Jul. 12, 2026) — Near Median


FRA:1M7 Cambridge Cognition Holdings PLC FRA:1M7
52 GF Score
Price €0.34
GF Value €0.35
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cambridge Cognition Holdings GF Score?

Cambridge Cognition Holdings FRA:1M7 -6.63% 52 GF Score is 52 as of Jul. 12, 2026, which is 4% above its 10-year median of 50.00. GuruFocus rates FRA:1M7 with a GF Score™ of 52/100 and a GF Value™ of €0.35 (Fairly Valued). The stock has 5 warning signs investors should review.

Cambridge Cognition Holdings has the GF Score of 52, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 2/10
3. Growth Rank : 6/10
4. GF Value Rank : 9/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Cambridge Cognition Holdings might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Cambridge Cognition Holdings  (FRA:1M7) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.


Cambridge Cognition Holdings GF Score Related Terms


FRA:1M7 vs VEEV, BTSG, TEM: GF Score Comparison

For the Health Information Services subindustry, Cambridge Cognition Holdings's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Cognition Holdings GF Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cambridge Cognition Holdings's GF Score distribution charts can be found below:

* The bar in red indicates where Cambridge Cognition Holdings's GF Score falls into.


FRA:1M7
52GF Score
Cambridge Cognition Holdings PLC FRA:1M7
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 52 mean?
Cambridge Cognition Holdings (FRA:1M7) has a GF Score of 52 as of Jul. 12, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cambridge Cognition Holdings and its competitors. This is near median its historical median of 50.00. Over the past decade, Cambridge Cognition Holdings' GF Score has ranged from 17.00 to 65.00.
Is Cambridge Cognition Holdings' GF Score too high?
Cambridge Cognition Holdings' current GF Score of 52 is near median its 10-year median of 50.00. Over the past 10 years, this metric has ranged from a low of 17.00 to a high of 65.00. Overall, Cambridge Cognition Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cambridge Cognition Holdings' GF Score compare to VEEV and BTSG?
Cambridge Cognition Holdings' GF Score of 52 can be compared against companies in the Healthcare Providers & Services industry. Historically, Cambridge Cognition Holdings' own GF Score has ranged from 17.00 to 65.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cambridge Cognition Holdings and its competitors. Cambridge Cognition Holdings's current GF Score is 52, which is near median its own 10-year median of 50.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Cognition Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Cognition Holdings (FRA:1M7) is currently considered Fairly Valued. The stock's GF Value™ is €0.35, compared to a current price of €0.34 — trading 3.4% below its estimated fair value. The current GF Score is 52, which is near median its 10-year median of 50.00. Cambridge Cognition Holdings' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Cambridge Cognition Holdings (FRA:1M7), the current GF Score is 52 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cambridge Cognition Holdings (FRA:1M7) Overvalued in 2026?

Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be undervalued. The current stock price of €0.34 is trading 3.4% below its estimated GF Value™ of €0.35. GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.

Key valuation signals for FRA:1M7:

  • GF Score: 52 (near median its 10-year median of 50.00)
  • GF Value™: €0.35 vs. price of €0.34 (3.4% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the FRA:1M7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cambridge Cognition Holdings Business Description

Other Exchanges COG:UK
Address Tunbridge Lane, Tunbridge Court, Bottisham, Cambridge, GBR, CB25 9TU
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
52GF Score

Get the complete analysis for FRA:1M7

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price
€0.35
GF Value